Assessing Brain Metabolism Using MRS With Deuterated Glucose

Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.

The trial team last updated this record on September 2, 2026.

What the trial team says

This study will investigate the use of Hydrogen 1 (1H) magnetic resonance spectroscopy (MRS) with deuterated glucose (2H-glucose) to detect dynamic glucose uptake in the brain.

From the trial's own listing on ClinicalTrials.gov.

Key facts

Registry number: NCT06594315
Conditions studied: Glioma

Where it is running

This trial lists 1 site.

California
- University of California, San Francisco (San Francisco)

How to use this

Talk to your care team first. They know your history and can tell you whether this trial is worth your time.

Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.

See the full listing on ClinicalTrials.gov

This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.